ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

ClinicalTrials.gov ID: NCT01362205

Public ClinicalTrials.gov record NCT01362205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 5:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Dexmedetomidine (Precedex®), With Lorazepam Rescue, for the Management of Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

Study identification

NCT ID
NCT01362205
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Denver Health and Hospital Authority
Other
Enrollment
49 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2012
Primary completion
Nov 30, 2015
Completion
Aug 31, 2016
Last update posted
Nov 5, 2017

2012 – 2016

United States locations

U.S. sites
7
U.S. states
3
U.S. cities
5
Facility City State ZIP Site status
Memorial Hospital Central Colorado Springs Colorado 80909
Memorial Hospital North Colorado Springs Colorado 80920
Denver Health Medical Center, Medical ICU Denver Colorado 80204
Porter Adventist Hospital Denver Colorado 80210
St. Anthony Hospital Lakewood Colorado 80228
Louisiana State University New Orleans Louisiana 70112
Ben Taub Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01362205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2017 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01362205 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →